The Super Rich: Start from when the family business is about to go bankrupt!

Chapter 193 WPG0192: Tsumura Pharmaceutical is in trouble! 334K
As for whether Wugengtian Pharmaceutical Group will go public and accept capital acquisition, that is impossible.

Wugengtian Pharmaceutical Group is not preparing to go public!
The reason is simple. There is no need for Wugengtian Pharmaceutical Group to go public.

Currently in Xiaguo's A-share market, the vast majority of listed companies choose to go public simply to raise funds through listing and defraud money, and then the shareholders cash out and leave, leaving a mess behind.

Wugengtian Pharmaceutical Group does not need to take such a deceptive route, so it will naturally not enter the A-share market.

As for the fact that there are good companies in the A-share market, An Wuyang does not deny it.

But if someone wants to persuade An Wuyang to invest in the A-share market, An Wuyang will only shake his head.

Wugengtian Pharmaceutical Group has no plans to list on the Hong Kong stock market, nor does it have any plans to list on the U.S. stock market.

Wugengtian Pharmaceutical Group is actually a very traditional family business, following the old tradition of passing down the business from father to son and then from son to son.

Such old traditions can no longer keep up with the development of the times, so the Wugengtian Pharmaceutical Group almost collapsed.

Modern enterprises prefer the manager system.

After all, through the manager system, better talents can be selected to manage the company, and there will not be too much loss when managers are eliminated.

This is the system that capital likes.

If a family-inherited business encounters an unreliable heir, it can easily cause huge losses to the family business.

For example, Anhuchun!
So as soon as An Wuyang became an adult, he began to get involved in the management of the family business. He was worried that he would not be able to become the third generation of wealth, but instead would become a negative generation.

Fortunately, An Wuyang has the Happy Life System, otherwise it would be very difficult for An Wuyang to turn the tide.

Unless An Wuyang chooses to give up his conscience!

Because without conscience, you will definitely earn more.

Now An Wuyang has a happy life system and he has retained his conscience.

In addition, Wugengtian Pharmaceutical Group will not accept capital acquisition. An Wuyang is very clear that with the assistance of the Happy Life System, Wugengtian Pharmaceutical Group will only develop better.

More importantly, if there is no Wugengtian Pharmaceutical Group, and only the Happy Life System, how can An Wuyang cash in the system rewards?
An Wuyang needs the support of Wugengtian Pharmaceutical Group, so it is naturally impossible for him to sell Wugengtian Pharmaceutical Group.

'An Wuyang: I see, we don't list or sell them at 5:00.'

'An Wuyang: I will go to our Wugengtian official website to update an announcement first.'

An Wuyang still has no intention of registering an official Weibo account, mainly because the current ecological environment of Weibo is too bad and An Wuyang doesn't want to go to the toilet to light a lamp.

An Wuyang quickly posted a message on the official website of Wugengtian Pharmaceutical Group.

……

Wugengtian Pharmaceutical Group Announcement:
First of all, I would like to thank Mr. Musk for his support for our products.

Secondly, our company has no plans for listing or financing for the time being, and no intention of selling the group company.

Finally, given that the current price of forest ginseng is too high, our company is not prepared to produce Ba Chun Xiao on a large scale.

……

An Wuyang's announcement formed a fantastic connection with Musk's Twitter message, and both messages revealed a key point - ginseng under the forest!

If only the announcement from Wugengtian Pharmaceutical Group indicated that the raw materials of Bachunxiao came from forest ginseng, it would probably still arouse people's suspicion.

But Musk's tweet proved that a new round of market trend for wild ginseng was immediately triggered.

Even though Wugengtian Pharmaceutical Group has clearly stated that the price of forest ginseng is too expensive and it is not prepared to mass-produce Bachunxiao, does that matter?

No production at five o'clock in the morning, right?

Some are companies that want to produce!

Although other companies are unable to produce Bachunxiao for the time being, they can reverse engineer Bachunxiao. As long as they crack the formula of Bachunxiao and then crack the production process, they can make Bachunxiao, right?

In addition, even if it is impossible to reverse-engineer the secret of Ba Chun Xiao in a short period of time, Ba Chun Xiao has also proved that forest ginseng is good for the human body. Should the price of forest ginseng be increased?
If someone refutes or doesn't believe it, they can cite Musk as an example, saying that such a famous figure has stood up for Ba Chunxiao, so how could there still be people questioning Lin Xiashen?

Based on the underlying logic of this inequality, forest ginseng has ushered in a new round of market growth.

Take the twelve-year-old forest ginseng as an example. Its price has doubled in the past two days, and is now continuing to rise.

Faced with a new round of rising prices, the first one to get restless was Tsumura Pharmaceutical.

Because the output of Jincun Pharmaceutical's two large ginseng plantations in Changbai Mountain for the next 20 years has been reserved using a low-price long-term supply contract.

What’s more crucial is that the relevant long-term supply contract was signed just two days ago.

There is obviously something wrong here!

Katsuaki Shibato, the second-in-charge of Tsumura Pharmaceutical's Natsukoku Commercial Investment, Chiki Matsui, the third-in-charge of Natsukoku Commercial Investment, and Naoto Kaneki, the head of the Changbaishan ginseng business, are holding a video conference.

Shibato Katsuaki spoke first, "Kaneki-kun, why did you make such a serious mistake?"

Facing Shibato Katsuaki's argument of directly assigning responsibility, Kaneki Naoto retorted, "Shibato-kun, our ginseng business department did not violate the regulations. When we signed the contract, the relevant ginseng market price was like this."

"From the perspective of our ginseng business department, the contract we signed with the company is very good. Not only is it a long-term contract for twenty years, it also stipulates that the purchase price can be increased by five percent each year, and production can be expanded by up to twenty percent," Naoto Kaneki added.

"Isn't such a long-term supply contract good?" Kaneki Naoto asked. Shibato Katsuaki snorted coldly, "Quibbling!"

"Look, the contract price you signed is only 2600 Xia Guoyuan for one kilogram of twelve-year-old forest ginseng. This price is far lower than the current market price." Shibato Katsuaki accused bluntly.

"The current price of dried ginseng from the forest aged twelve years has exceeded 5500 Xia Guoyuan per kilogram, and the price is still rising. I have reason to suspect that you have colluded with outsiders to embezzle the company's assets!" Shibato Katsuaki continued to accuse me.

Chiki Matsui did not participate in the "friendly exchange" between the two. He knew that Katsuaki Shibato and Naoto Kaneki had a personal grudge. Now that Naoto Kaneki has caused losses to the company, Katsuaki Shibato will of course take the opportunity to target Naoto Kaneki.

"The current price has indeed increased, but this is normal market price fluctuation. We couldn't have anticipated such a thing when we signed the contract." Naoto Kaneki tried to defend himself.

Kaneki Naoto added, "Also, don't make my problem too serious. Although the contract we signed is for a 20-year supply period, in fact our long-term supply contract only has a three-year supply period, plus a 17-year priority supply contract."

"For example, a company called Guhong Pharmaceutical has reserved 8000 million worth of forest ginseng in our Baijin Ginseng Garden and paid a pre-order fee of 1600 million Xia Guoyuan. In fact, we have only signed a three-year supply period for the forest ginseng it has reserved, and the remaining years are only a priority supply contract." Naoto Kaneki gave an example.

Kaneki Naoto continued, "We can completely choose to breach the contract and cancel this long-term supply contract."

"Although according to the contract, we unilaterally breached the contract and will pay the other party a penalty of 2.4 million Xia Guoyuan, this penalty can be paid slowly, and as the price of forest ginseng increases, we will earn back the penalty in the future," added Naoto Kaneki.

While Kaneki Naoto was explaining himself, a new user came into the video conference room. His user name was Shono Shinsuke, and he was the first person in charge of Tsumura Pharmaceutical's commercial investment in Xia Country.

After listening to Kaneki Naoto's explanation, Shono Shinsuke said, "Kaneki-kun has a point. Although we have suffered some losses, the profits brought by the current increase in the price of forest ginseng can fully make up for these losses."

"Last year, our Baijin Ginseng Garden harvested a total of 2.2 million Xia Guoyuan worth of forest ginseng. This year's output is expected to increase further. Conservative estimates show that there are 2.4 million Xia Guoyuan worth of forest ginseng. According to the current price increase, the extra income brought by this year's output alone can pay the corresponding penalty." Shono Shinsuke explained.

The ginseng industry is very large in the three provinces of Changbai Mountain. Taking Lingji Province as an example, in 2020, the scale of ginseng trading in Lingji Province exceeded 500 billion Xia Guoyuan, and the economic scale driven by the entire industrial chain is even larger.

Baijin Ginseng Garden can only be considered a large ginseng garden among many ginseng gardens, and its annual output ranking does not even rank among the top ten.

Facing Shono Shinsuke's protection, Shibato Katsuaki snorted and said, "The compensation for Guhong Pharmaceutical is 2.4 million, and there are also compensations for the other six pharmaceutical companies, as well as the breach of contract compensation for Futsu Sanen. The total is 8 million Xia Guoyuan."

"With such a huge loss, are you sure you want to protect Kaneki-kun, Shono-kun?" Shibato Katsuaki sneered.

Shono Shinsuke couldn't help but frown. He originally thought that there was only a mistake of 2.4 million Xia Guoyuan, but Naoto Kaneki caused such a big mess for him?
Kaneki Naoto saw Shono Shinsuke's frowning face through the video, and he immediately added, "I'm sorry, I did cause huge losses to the company this time, but I just signed a new cooperation agreement with the Linji court, and our Shiratsu Ginseng Garden and Futsu Ginseng Garden can expand their planting area by twice."

"After this round of expansion of forest ginseng production, we can make back all our past losses in one go!" Naoto Kaneki vowed.

Shono Shinsuke did not make an arbitrary decision. He responded, "I will contact the headquarters about this matter and wait for their decision."

"Kaneki-kun, please put down your work for the time being and leave it to Ariki-kun." Shono Shinsuke added.

Ariki Hisanami is the second-in-charge of Tsumura Pharmaceutical's ginseng business in the Changbai Mountain area. He is a very shrewd man. He even suspected whether there was anything wrong with such large-scale and intensive pre-ordering of forest ginseng and signing of long-term supply contracts.

But unfortunately, he was the second in charge, and the first person in charge, Kaneki Naoto, still thought that he wanted to seize power, so Arikumi Shounan did not stop him.

When the video conference ended, Shono Shinsuke immediately contacted Ariki Hisanami and said, "Ariki-kun, the management of the Changbaishan ginseng business department is now temporarily handed over to you. Do not sign any ginseng supply contracts for now. Do you understand?"

Arimi Shounan answered affirmatively, "I understand!"

"Mr. Shouno, I had doubts about the circumstances of these contracts before, and then I investigated the companies that signed the contracts. All the companies that signed contracts with our Shenyuan were newly registered companies. I suspect this is a deliberate scam that has been planned for a long time." Arikuki Hisan said quickly.

"These companies may be related to Gogentian," added Ariki Hisanan.

But he guessed in the wrong direction!
Shono Shinsuke was silent for a few seconds before responding, "I'll investigate!"

"Try to contact the companies that have signed long-term supply contracts with us and see if you can terminate the contracts privately," added Shono Shinsuke.

"Hi!" Arimi Shounan responded affirmatively.

While Tsumura Pharmaceutical was holding a high-level meeting in Xia State, Lin Qianli led his men to conduct negotiations in the three provinces of Changbai Mountain. They made different degrees of compromise based on the background of the relevant agricultural companies and ginseng gardens.

The lowest compensation for breach of contract is just returning the deposit, which is equivalent to no compensation at all.

Because behind the corresponding agricultural companies stands the second-level interpersonal network of the imperial capital circle.

Both Chen Hongzhi and Lin Qianli need to consider this level of interpersonal network carefully.

After all, the plan they planned to hype up the price of forest ginseng was not something particularly glorious. It could even be said that they had joined forces with the Wugengtian Pharmaceutical Group to deliberately deceive the market and maliciously hype up the price of forest ginseng.

Given this situation, Lin Qianli would naturally not make things difficult for agricultural companies and ginseng gardens that have particularly deep interpersonal networks.

The highlight of the liquidated damages lies with five overseas companies!

For example, Tsumura Pharmaceutical alone will have to bear 8 million in breach of contract compensation.

What’s more important is that it is difficult for Tsumura Pharmaceutical not to pay compensation!

The reason is simple. Jincun Pharmaceutical has too many industries in Xia Country, including a large number of GAP medicinal materials planting bases, medicinal materials processing enterprises, and special medicinal materials bases like Shenyuan.

In the three provinces of Changbai Mountain alone, Jincun Pharmaceutical has a total of 11 ginseng gardens of various sizes!
When Tsumura Pharmaceutical has so many assets in Xia Country, can Tsumura Pharmaceutical still fail to comply with the laws of Xia Country?
For example, regarding the long-term supply contract for wild ginseng, did anyone force Tsumura Pharmaceutical to sign the contract?

not at all!
Is someone forcing Tsumura Pharmaceutical to breach the contract again?
still none!

Whether signing a long-term supply contract or choosing to unilaterally terminate the contract, there is only one reason, that is, Tsumura Pharmaceutical saw the benefits.

The long-term supply contract was signed because it can bring profits. After all, the long-term supply of forest ginseng is one of the main businesses of the ginseng garden under Tsumura Pharmaceutical.

As for unilateral breach of contract, it is the better choice made after weighing the pros and cons.

If you can make more money by unilaterally breaking the contract, why not break it?
(End of this chapter)